Αποτελέσματα Αναζήτησης
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a longitudinal, multi-center, observational study. The overall goal of ADNI is to validate biomarkers for Alzheimer’s disease (AD) clinical trials.
- About
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- News & Publications
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) is a...
- HELP / FAQ
Study Documents page if you’re looking for study schedules...
- About
Clinical Trials. Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) Start: June 2023. End: July 2027. Enrollment: 1500. What Is This Study About? The ADNI4 study is the fourth in a series of trials since 2004 to identify markers for diagnosing and tracking the progression of Alzheimer's disease.
The Alzheimer’s Disease Neuroimaging Initiative (ADNI) beginning in October 2004, is a 6-year re-search project that studies changes of cognition, function, brain structure and function, and biomarkers in elderly controls, subjects with mild cognitive impairment, and subjects with Alzheimer’s disease (AD).
Study Documents page if you’re looking for study schedules or documents. Background & Rationale page if you’re looking for details about study cohorts. Study Design page if you’re looking for an overview of ADNI and its phases.
12 Σεπ 2023 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) aims to improve Alzheimer's disease (AD) clinical trials. Since 2006, ADNI has shared clinical, neuroimaging, and cognitive data, and biofluid samples. We used conventional search methods to identify 1459 publications from 2021 to 2022 using ADNI data/samples and reviewed 291 impactful studies.
28 Σεπ 2021 · The Alzheimer's Disease Neuroimaging Initiative (ADNI) has accumulated 15 years of clinical, neuroimaging, cognitive, biofluid biomarker and genetic data, and biofluid samples available to researchers, resulting in more than 3500 publications. This review covers studies from 2018 to 2020.
19 Σεπ 2008 · ADNI PREPARATORY STUDY. This study will be completed before the main ADNI study is initiated. During this preparatory phase, subjects with AD and normal controls (N=~60 AD and ~60 NL) will be recruited for testing on 6 platforms at 5 sites. These subjects will be recruited from existing ADC populations.
